Single protein production in living cells facilitated by a messenger RNA interferase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7985575
APP PUB NO 20100035346A1
SERIAL NO

11750314

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

cells that exploits the unique properties of an mRNA interferase, for example, MazF, a bacterial toxin that is a single stranded RNA- and ACA-specific endoribonuclease, which efficiently and selectively degrades all cellular mRNAs in vivo, resulting in a precipitous drop in total protein synthesis. Concomitant expression of MazF and a target gene engineered to encode an ACA-less mRNA results in sustained and high-level (up to 90%) target expression in the virtual absence of background cellular protein synthesis. Remarkably, target synthesis continues for at least 4 days, indicating that cells retain transcriptional and translational competence despite their growth arrest. SPP technology works well for yeast and human proteins, even a bacterial integral membrane protein. This novel system enables unparalleled signal to noise ratios that should dramatically simplify structural and functional studies of previously intractable but biologically important proteins. The present invention also provides an optimized condensed single protein production system.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Inouye, Masayori New Brunswick, US 64 942
Suzuki, Motoo Kagawa-Ken, JP 10 80
Zhang, Junjie Beijing, CN 46 58

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation